Rohit Kapoor
Analyst · William Blair & Company
Thank you, Charlie, and welcome, everyone, to our third quarter earnings call. First of all, I want to extend our concerns and sympathies to our colleagues and neighbors dealing with the aftermath of Hurricane Sandy over the last several days. We greatly admire how everyone has pulled together in this difficult time, including here at Exl, where we are fortunate to have all our employees safe and focused on delivering differentiated value to our clients.
The agenda for the morning's call will be as follows: first, I will discuss recent business highlights, including our strategic account win; second, I will discuss 2 of our fastest growing businesses, health care and analytics; third, I will discuss our updated 2012 guidance; fourth, I will comment on the demand environment. I will then turn the call to Vishal, who will discuss the third quarter financials and our outlook in more detail. Following Vishal's comments, we would be happy to take your questions.
Exl generated solid growth in the third quarter. Revenue increased 17.5% year-over-year on a constant currency basis, driven by robust growth in our outsourcing and transformation businesses. Key drivers of year-over-year growth were increasing relationships with large existing clients in our insurance, health care and utilities outsourcing practices, new and expanded analytics relationships with global banks and our Trumbull acquisition. Revenue growth, operating efficiencies and operating leverage fueled 21% year-over-year adjusted EPS growth. I'm pleased to announce that we won a new strategic account for finance and accounting or F&A outsourcing services with a leading speciality insurer. This win is important for several reasons. First, it validates and extends our F&A capabilities, which we enhanced last year through the acquisition of OPI. Second, it strengthens our dominant position in insurance operations management, which remains our single largest business and a key driver of our growth. Third, it was won against significant competition, validating our business model and competitive position, and fourth, it starts a large relationship with a top-tier customer with attractive opportunities for future growth.
Health care is a strategic domain for Exl, and we are actively investing in this vertical. Three weeks ago, we acquired Landacorp, a leading provider of health care solutions and technology, significantly expanding our capabilities in the health care domain. Integration is already well underway, and we are encouraged to have Landacorp's team join us, as we together capture the robust growth opportunity in health care. As we said on our October 16 conference call, announcing this acquisition, we will capture this growth opportunity both by leveraging Landacorp's leading market position amongst peers, as well as by expanding our clinical resources.
In our key health care client markets, clinical talent remains scarce. Simultaneously, demand for differentiated health care operations management and analytics is robust and increasing rapidly. To address this opportunity, in October, we launched the Exl Healthcare Academy in Manila. Our new academy will ensure we are adequately training highly qualified Exl employees to meet the demand for clinical talent, bolstering our position as a leading provider of health care operations, analytics and technology solutions.
Our analytics franchise continues to grow in importance for Exl. Our analytics business has tripled in the last 3 years, and is now driving a meaningful portion of Exl's overall growth. In the third quarter, for example, over 20% of our year-over-year top line growth was driven by analytics. And the majority of our analytics business is recurring, enhancing our revenue and earnings visibility. We have acquired 13 new analytics clients year-to-date, and the business sales pipeline is amongst the strongest at Exl. At a macro level, the analytics market is growing rapidly. Our recent NASSCOM study forecasted the global big data market to grow at a 45% compounded annual growth rate over the next 3 years. Our analytics business is differentiated by a few factors. First of all, by domain expertise, which is valued very highly by our clients. We have built a world-class banking analytics practice, with 5 of the top global banks as clients. The current regulatory environment and our recent win have helped us initiate new business discussions with some of the world's largest financial institutions for high-end analytics relationships. We have also built a rapidly growing analytics team, specializing in healthcare, performing sophisticated analysis such as medical cost analytics and claims overpayment identification.
And finally, we have built a top-tier insurance analytics team, providing critical operations and marketing analytics for some of the largest U.S. property and casualty insurers. We are also differentiated in analytics by our intellectual property. Over the last few years, we have made strong investments in our methodologies and product teams, which are now generating attractive returns. As an example, Exl is currently ranked #1 out of 1,400 competitors in the Heritage Health Price competition, a 2-year project, challenging analytics teams globally to create an algorithm based on historical claims data that best predicts future hospital patient volumes. Exl has created proprietary tools and techniques for this project, which are now being leveraged across key accounts to create significant business impact. And across our analytics business, we utilized Exl's patent-pending microanalytics methodology.
Microanalytics is a compilation of continually updated best practices and cutting-edge thinking, designed to enhance efficiency and quality at each stage of the analytic life cycle from data collection and preparation to model evaluation and stabilization. Finally, we are differentiated by the quality and size of our analytics team. Exl now employs one of the largest and most talented analytics team in India, as well as analytics professionals in the U.S., Europe and Asia-Pacific. We are recruiting aggressively and have built a leading presence at many of the finest global educational institutions in order to find and hire the world's next premier data scientist and engineers. In fact, in 2012, we recruited our largest class ever from the Indian Institute of Technology and the Indian Institute of Management in India. In summary, there is a robust secular growth opportunity in analytics, and we are extremely well-positioned due to our domain expertise, intellectual property, talent and leadership position. We remain confident of growing this business significantly.
Turning to our updated 2012 annual guidance. We see revenue of between $442 million and $444 million and adjusted earnings per share of $1.52 to $1.57, partially offsetting the positive incremental effects of an appreciating rupee, third quarter results and our Landacorp acquisition. We have experienced some client transitions based on commercial considerations in the OPI portfolio we acquired last year. Some client transitioning is a natural part of integrating a deal as large as OPI. These transitioning clients are low-margin, onshore heavy contracts in non-focus verticals. In 2013, these client transitions will impact our revenue growth rate by 5 to 6 percentage points, but will have only a marginal impact on our adjusted earnings per share growth.
On the demand environment, we continue to see strong demand for smaller deals, as our 23 new client wins to date prove. Lately, we've noticed a pick up in demand for large deals in finance and accounting, health care, banking and analytics. We are seeing more large deals than we have in the past, and competition for these large outsourcing deals remains aggressive. Meanwhile, opportunities to expand with our existing client base continue to be strong. This is being driven by 3 factors: first, increasing client satisfaction versus last year; second, our strong investment over the last 2 years in growing and improving our front-end personnel; third, from delivering superior business impacts to our clients just this year through our proprietary operations management framework. I remain optimistic about Exl's revenue and earnings growth prospects over the coming years, and look forward to executing on this exciting and unique growth opportunities ahead. And now I will turn the call over to Vishal.